---  
layout: startup_page  
title: "AIRNA"  
id: "airna.com"  
permalink: "/airnaairna.com04012025/"  
website: "https://www.airna.com/"  
funding_round: "Series B"  
funding_amount: "$155M"  
investors: "Venrock Healthcare Capital Partners, Forbion Growth, RTW Investments, Nextech Invest, ARCH Venture Partners, Forbion Ventures, ND Capital"  
about: "AIRNA is a biotech company developing RNA editing therapeutics for rare and common diseases. Its lead product candidate, AIR-001, targets Alpha-1 antitrypsin deficiency (AATD), aiming to provide a functional cure. The company's proprietary platform allows for precise RNA editing with potent, durable, and safe treatment."  
markets: "Biotechnology, RNA Editing, Rare Disease, Genetic Medicine"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/airna-bio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/airna"  
pitchbook: "https://pitchbook.com/profiles/company/535770-01"  

date_display: "01-Apr-2025"  
date: "2025-04-01"

# SEO Optimization  
meta_title: "AIRNA - Series B Funding ($155M)"  
meta_description: "AIRNA, AIRNA is a biotech company developing RNA editing therapeutics for rare and common diseases. Its lead product candidate, AIR-001, targets Alpha-1 anti..."  
meta_keywords: "AIRNA, Biotechnology, RNA Editing, Rare Disease, Genetic Medicine, Series B funding"  
canonical_url: "https://startup.projectstartups.com/airnaairna.com04012025/"  
---